{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:55:51Z","timestamp":1792742151419,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100020884","name":"ANID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.xphs.2023.08.011","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T11:10:56Z","timestamp":1692184256000},"page":"3175-3184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intramuscularly Administered PLGA Microparticles for Sustained Release of Rivastigmine: In Vitro, In Vivo and Histological Evaluation"],"prefix":"10.1016","volume":"112","author":[{"given":"Javier","family":"Avenda\u00f1o-Godoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoldo","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Mennickent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2080-9870","authenticated-orcid":false,"given":"Carolina","family":"G\u00f3mez-Gaete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2023.08.011_bib0001","unstructured":"OMS. Demencia 2020 [Available from:https:\/\/www.who.int\/es\/news-room\/fact-sheets\/detail\/dementia#:\u223c:text=La%20demencia%20afecta%20a%20nivel,demencia%20en%20un%20determinado%20momento."},{"issue":"7","key":"10.1016\/j.xphs.2023.08.011_bib0002","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.xphs.2023.08.011_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic signaling in Alzheimer's disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2023.08.011_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.xphs.2023.08.011_bib0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/ADR-210061","article-title":"Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for alzheimer's disease and future perspectives","volume":"6","author":"Moreira","year":"2022","journal-title":"J Alzheimers Dis Rep"},{"issue":"6","key":"10.1016\/j.xphs.2023.08.011_bib0006","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0149-2918(03)80160-1","article-title":"A review of rivastigmine: a reversible cholinesterase inhibitor","volume":"25","author":"Williams","year":"2003","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.xphs.2023.08.011_bib0007","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1742-1241.2009.02052.x","article-title":"Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review","volume":"63","author":"Kurz","year":"2009","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10.1016\/j.xphs.2023.08.011_bib0008","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40262-013-0038-9","article-title":"Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease","volume":"52","author":"Noetzli","year":"2013","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0009","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/2042098617750555","article-title":"An update on the safety of current therapies for Alzheimer's disease: focus on rivastigmine","volume":"9","author":"Khoury","year":"2018","journal-title":"Ther Adv Drug Saf"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2478\/v10007-008-0014-3","article-title":"A study of rivastigmine liposomes for delivery into the brain through intranasal route","volume":"58","author":"Arumugam","year":"2008","journal-title":"Acta Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.08.011_bib0011","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijpharm.2013.05.009","article-title":"Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration","volume":"452","author":"Yang","year":"2013","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2023.08.011_bib0012","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3109\/10717544.2013.878857","article-title":"Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization","volume":"22","author":"Shah","year":"2015","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2023.08.011_bib0013","article-title":"Biodistribution and amyloid beta induced cell line toxicity study of intranasal rivastigmine microemulsion enriched with fish oil and butter oil","volume":"57","author":"Khunt","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0014","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3109\/03639045.2012.665926","article-title":"Buccoadhesive films for once-a-day administration of rivastigmine: systematic formulation development and pharmacokinetic evaluation","volume":"39","author":"Kapil","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2023.08.011_bib0015","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11095-007-9384-3","article-title":"In situ-forming oleogel omplant for rivastigmine delivery","volume":"25","author":"Vintiloiu","year":"2008","journal-title":"Pharm Res."},{"issue":"1","key":"10.1016\/j.xphs.2023.08.011_bib0016","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejps.2012.04.013","article-title":"Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting","volume":"47","author":"Fazil","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.08.011_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.960246","article-title":"QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics","volume":"14","author":"Arora","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.xphs.2023.08.011_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/ph14010066","article-title":"In situ-forming microparticles for controlled release of rivastigmine: in vitro optimization and in vivo evaluation","volume":"14","author":"Haider","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.xphs.2023.08.011_bib0019","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jconrel.2011.08.171","article-title":"Preparation and evaluation of injectable sustained-release microspheres of rivastigmine","volume":"152","author":"Zhu","year":"2011","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/scipharm87030020","article-title":"Microparticles, microspheres, and microcapsules for advanced drug delivery","volume":"87","author":"Lengyel","year":"2019","journal-title":"Sci Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2023.08.011_bib0021","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2016015798","article-title":"Overview on therapeutic applications of microparticulate drug delivery systems","volume":"33","author":"Bale","year":"2016","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"4","key":"10.1016\/j.xphs.2023.08.011_bib0022","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s40204-020-00139-y","article-title":"Recent advances in the formulation of PLGA microparticles for controlled drug delivery","volume":"9","author":"Lagreca","year":"2020","journal-title":"Prog Biomater"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.011_bib0023","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/pharmaceutics14020359","article-title":"Poly(lactic acid)-based microparticles for drug delivery applications: an overview of recent advances","volume":"14","author":"Vlachopoulos","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.08.011_bib0024","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijpharm.2012.09.024","article-title":"Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinson's disease","volume":"438","author":"Fern\u00e1ndez","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.08.011_bib0025","unstructured":"ICH. ICH Harmonised tripartite guideline validation of analytical procedures: text and methodology Q2 (R1). 2005."},{"issue":"9","key":"10.1016\/j.xphs.2023.08.011_bib0026","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.polymer.2005.01.075","article-title":"Monodispersed thermoresponsive hydrogel microspheres with a volume phase transition driven by hydrogen bonding","volume":"46","author":"Xiao","year":"2005","journal-title":"Polymer"},{"key":"10.1016\/j.xphs.2023.08.011_bib0027","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fbp.2022.04.007","article-title":"Prototypes of nutraceutical products from microparticles loaded with stilbenes extracted from grape cane","volume":"134","author":"Avenda\u00f1o-Godoy","year":"2022","journal-title":"Food Bioprod Process"},{"key":"10.1016\/j.xphs.2023.08.011_bib0028","series-title":"Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms","year":"1997"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0029","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2023.08.011_bib0030","series-title":"Gu\u00eda para la realizaci\u00f3n y presentaci\u00f3n de estudios de estabilidad","year":"2006"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0031","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(99)00643-3","article-title":"Effect of rivastigmine on scopolamine-induced memory impairment in rats","volume":"383","author":"Bejar","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0032","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0028-3908(99)00157-4","article-title":"Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats","volume":"39","author":"Wang","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.xphs.2023.08.011_bib0033","series-title":"Manual of Stroke Models in Rats","author":"Wang-Fischer","year":"2008"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0034","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/02652040903131301","article-title":"Microencapsulation techniques, factors influencing encapsulation efficiency","volume":"27","author":"Jyothi","year":"2010","journal-title":"J Microencapsul"},{"issue":"9","key":"10.1016\/j.xphs.2023.08.011_bib0035","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.actbio.2011.05.036","article-title":"In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres","volume":"7","author":"Lanao","year":"2011","journal-title":"Acta Biomater"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.08.011_bib0036","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2008.07.018","article-title":"Microencapsulation by solvent evaporation: state of the art for process engineering approaches","volume":"363","author":"Li","year":"2008","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2023.08.011_bib0037","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/00914037.2018.1434652","article-title":"Preparation and characterization of miglitol-loaded Poly (d, l-lactide-co-glycolide) microparticles using high pressure homogenization-solvent evaporation method","volume":"68","author":"Waghulde","year":"2018","journal-title":"Int J Polym Mater"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.011_bib0038","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jconrel.2004.10.015","article-title":"Microencapsulation by solvent extraction\/evaporation: reviewing the state of the art of microsphere preparation process technology","volume":"102","author":"Freitas","year":"2005","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.xphs.2023.08.011_bib0039","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1002\/app.35327","article-title":"Tamoxifen-loaded microspheres based on mixtures of poly(D,L-lactide-co-glycolide) and poly(D,L-lactide) polymers: effect of polymeric composition on drug release and in vitro antitumoral activity","volume":"124","author":"Fen\u00e1ndez","year":"2012","journal-title":"J Appl Polym Sci"},{"key":"10.1016\/j.xphs.2023.08.011_bib0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jconrel.2022.04.051","article-title":"Core-shell microneedle patch for six-month controlled-release contraceptive delivery","volume":"347","author":"Li","year":"2022","journal-title":"J Control Release"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.08.011_bib0041","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2018.05.066","article-title":"Improved design and characterization of PLGA\/PLA-coated chitosan based micro-implants for controlled release of hydrophilic drugs","volume":"547","author":"Manna","year":"2018","journal-title":"Int J Pharm"},{"issue":"0","key":"10.1016\/j.xphs.2023.08.011_bib0042","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.addr.2012.09.004","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"64","author":"Anderson","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0043","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.011_bib0044","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4314\/tjpr.v11i2.19","article-title":"Injectable in situ forming microparticles: a novel drug delivery system","volume":"11","author":"Yapar","year":"2012","journal-title":"Trop J Pharm Res"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.08.011_bib0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2007.03.022","article-title":"Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers","volume":"121","author":"Champion","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2023.08.011_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2019.109353","article-title":"Role of particle shape on efficient and organ-based drug delivery","volume":"122","author":"Nejati","year":"2020","journal-title":"Eur Polym J"},{"key":"10.1016\/j.xphs.2023.08.011_bib0047","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejps.2016.10.010","article-title":"Development, characterization and in vitro evaluation of biodegradable rhein-loaded microparticles for treatment of osteoarthritis","volume":"96","author":"G\u00f3mez-Gaete","year":"2017","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0048","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3797\/scipharm.1211-20","article-title":"Rivastigmine-loaded L-lactide-dessipeptide polymeric nanoparticles: decisive formulation variable optimization","volume":"81","author":"Pagar","year":"2013","journal-title":"Sci Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.08.011_bib0049","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2016.01.066","article-title":"Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate","volume":"501","author":"Simon","year":"2016","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2023.08.011_bib0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.15171\/apb.2020.003","article-title":"Formulation and evaluation of eudragit RL-100 nanoparticles loaded in-situ forming gel for intranasal delivery of rivastigmine","volume":"10","author":"Salatin","year":"2020","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.xphs.2023.08.011_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2021.02.015","article-title":"Design, development and in-vitro\/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer's disease","volume":"163","author":"Kulkarni","year":"2021","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2023.08.011_bib0052","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.snb.2013.07.092","article-title":"Voltammetric determination of rivastigmine in pharmaceutical and biological samples using molecularly imprinted polymer modified carbon paste electrode","volume":"188","author":"Arvand","year":"2013","journal-title":"Sens Actuators B"},{"key":"10.1016\/j.xphs.2023.08.011_bib0053","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4236\/jbnb.2012.32027","article-title":"Synthesis and Characterization of poly(D,L-Lactide-co-glycolide) copolymer","volume":"3","author":"Carvalho","year":"2012","journal-title":"J Biomater Nanobiotechnol"},{"issue":"11","key":"10.1016\/j.xphs.2023.08.011_bib0054","doi-asserted-by":"crossref","first-page":"12478","DOI":"10.1021\/acsami.9b22425","article-title":"A novel transdermal protein delivery strategy via electrohydrodynamic coating of PLGA microparticles onto microneedles","volume":"12","author":"Angkawinitwong","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"issue":"11","key":"10.1016\/j.xphs.2023.08.011_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/coatings9110704","article-title":"Effect of preparation parameters on microparticles with high loading capacity and adsorption property adsorbed on functional paper","volume":"9","author":"Xiao","year":"2019","journal-title":"Coatings"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0056","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1208\/s12248-010-9184-2","article-title":"Online monitoring of PLGA microparticles formation using lasentec focused beam reflectance (FBRM) and particle video microscope (PVM)","volume":"12","author":"Zidan","year":"2010","journal-title":"AAPS J"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0057","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.xphs.2022.11.003","article-title":"Evaluation of the effects of gamma radiation sterilization on rhein-loaded biodegradable microparticles for the treatment of osteoarthritis","volume":"112","author":"Avenda\u00f1o-Godoy","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.08.011_bib0058","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejps.2016.10.010","article-title":"Development, characterization and in vitro evaluation of biodegradable rhein-loaded microparticles for treatment of osteoarthritis","volume":"96","author":"G\u00f3mez-Gaete","year":"2017","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.011_bib0059","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejpb.2010.07.007","article-title":"Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies","volume":"76","author":"Joshi","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2023.08.011_bib0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.colsurfb.2017.08.031","article-title":"Thermosensitive in situ nanocomposite of rivastigmine hydrogen tartrate as an intranasal delivery system: development, characterization, ex vivo permeation and cellular studies","volume":"159","author":"Salatin","year":"2017","journal-title":"Colloids Surf B"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.011_bib0061","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/acs.molpharmaceut.6b00896","article-title":"Effect of particle size on drug loading and release kinetics of gefitinib-loaded PLGA microspheres","volume":"14","author":"Chen","year":"2017","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0062","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0063","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/10543409708835198","article-title":"Multipoint dissolution specification and acceptance sampling rule based on profile modeling and principal component analysis","volume":"7","author":"Tsong","year":"1997","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.xphs.2023.08.011_bib0064","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.fbp.2018.08.011","article-title":"Storage stability and simulated gastrointestinal release of spray dried grape marc phenolics","volume":"112","author":"Moreno","year":"2018","journal-title":"Food Bioprod Process"},{"key":"10.1016\/j.xphs.2023.08.011_bib0065","first-page":"117","article-title":"Preparation of rooibos extract-chitosan microparticles: physicochemical characterisation and stability of aspalathin during accelerated storage","author":"Human","year":"2020","journal-title":"LWT - Food Sci Technol"},{"issue":"5","key":"10.1016\/j.xphs.2023.08.011_bib0066","doi-asserted-by":"crossref","DOI":"10.3390\/polym14050993","article-title":"Glass transition temperature of PLGA particles and the influence on drug delivery applications","volume":"14","author":"Liu","year":"2022","journal-title":"Polymers"},{"issue":"6","key":"10.1016\/j.xphs.2023.08.011_bib0067","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1556\/JPC.20.2007.6.12","article-title":"Stability-indicating HPTLC determination of rivastigmine in the bulk drug and in pharmaceutical dosage forms","volume":"20","author":"Karthik","year":"2007","journal-title":"J Planar Chromatogr - Mod TLC"},{"issue":"1","key":"10.1016\/j.xphs.2023.08.011_bib0068","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1163\/156856201744425","article-title":"Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic\/glycolic acid polymers. Part II: Biodegradation","volume":"12","author":"Wu","year":"2001","journal-title":"J Biomater Sci Polym"},{"key":"10.1016\/j.xphs.2023.08.011_bib0069","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2015.05.001","article-title":"Capreomycin oleate microparticles for intramuscular administration: preparation, in vitro release and preliminary in vivo evaluation","volume":"209","author":"Cambronero-Rojas","year":"2015","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.011_bib0070","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuropharm.2004.04.009","article-title":"Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain","volume":"47","author":"Enz","year":"2004","journal-title":"Neuropharmacology"},{"issue":"17","key":"10.1016\/j.xphs.2023.08.011_bib0071","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1016\/j.bmc.2014.07.009","article-title":"Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer's disease therapy","volume":"22","author":"Li","year":"2014","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"10.1016\/j.xphs.2023.08.011_bib0072","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071510","article-title":"Novel rivastigmine derivatives as promising multi-target compounds for potential treatment of Alzheimer's disease","volume":"10","author":"Vicente-Zurdo","year":"2022","journal-title":"Biomedicines"},{"issue":"61","key":"10.1016\/j.xphs.2023.08.011_bib0073","doi-asserted-by":"crossref","first-page":"35677","DOI":"10.1039\/C9RA06913E","article-title":"Effects and formulation of silver nanoscaffolds on cytotoxicity dependent ion release kinetics towards enhanced excision wound healing patterns in Wistar albino rats","volume":"9","author":"Sethuram","year":"2019","journal-title":"RSC Adv"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.011_bib0074","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4067\/S0717-95022011000200016","article-title":"Morphometric and histopathologic changes in skeletal muscle induced for injectable PLGA microparticles","volume":"29","author":"Acu\u00f1a","year":"2011","journal-title":"Int J Morphol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923003295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923003295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:43:21Z","timestamp":1758361401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923003295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0022354923003295"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.08.011","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intramuscularly Administered PLGA Microparticles for Sustained Release of Rivastigmine: In Vitro, In Vivo and Histological Evaluation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}